Onconova Therapeutics, Inc.
NASDAQ:ONTX
0.9953 (USD) • At close April 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -18.948 | -18.964 | -16.163 | -25.157 | -21.503 | -20.41 | -24.092 | -19.667 | -24.023 | -63.795 | -62.556 | -29.912 | -26.294 |
| Depreciation & Amortization
| 0.016 | 0.014 | 0.014 | 0.013 | 0.014 | 0.055 | 0.088 | 0.096 | 0.15 | 0.434 | 0.446 | 0.319 | 0.316 |
| Deferred Income Tax
| -1,770,000 | -0.098 | 0 | 0 | 0 | -0.163 | 0 | 0 | 0.044 | -0.02 | -0.042 | 8.194 | -1.287 |
| Stock Based Compensation
| 1.301 | 1.172 | 0.576 | 0.369 | 1.048 | 1.147 | 1.71 | 3.929 | 3.786 | 5.068 | 8.015 | 13.844 | 0.006 |
| Change In Working Capital
| -0.301 | 1.484 | -3.593 | 1.492 | -0.327 | -1.067 | 0.102 | 3.817 | -11.173 | 0.671 | -7.243 | 9.555 | 13.067 |
| Accounts Receivables
| 11,000 | -0.001 | 9,000 | 0.061 | -63,000 | 24,000 | -28,000 | 1.473 | -1.372 | 0 | 0 | 0 | 0 |
| Inventory
| -11,001.834 | 0 | -9,000 | -0.061 | 63,000 | -23,999.215 | 27,999.693 | 0.897 | -0.814 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 1.759 | 1.103 | -2.076 | 0.562 | 0.232 | -1.454 | 0.863 | 1.902 | -0.606 | 0.317 | -1.807 | -0.097 | 2.23 |
| Other Working Capital
| -0.226 | 0.382 | -1.517 | 0.93 | -0.559 | -0.398 | -0.454 | -0.455 | -8.381 | 0.354 | -5.436 | 9.652 | 10.837 |
| Other Non Cash Items
| 1,770,000 | 0.098 | -0.321 | 0.208 | -0.063 | -2.258 | -1.628 | -3.988 | -0.022 | -0.006 | -0.004 | -0.367 | 0.021 |
| Operating Cash Flow
| -17.932 | -16.294 | -19.487 | -23.075 | -20.831 | -22.696 | -23.82 | -15.813 | -31.238 | -57.648 | -61.384 | 1.633 | -14.171 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -0.014 | 0 | 0 | -0.015 | -0.055 | 0 | 0 | 0 | 0 | -0.228 | -0.609 | -0.279 | -0.256 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.99 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.015 |
| Investing Cash Flow
| -0.014 | 0 | 0 | -0.015 | -0.055 | 0 | 0 | 0 | 0 | 39.772 | -40.599 | -0.279 | -0.241 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.917 |
| Common Stock Issued
| 0 | 0 | 55.041 | 9.062 | 21.759 | 0 | 6.36 | 17.42 | 7.464 | 0 | 79.811 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | 0.519 | 10.295 | 4.889 | 35.657 | 0 | 0.003 | 0 | 1.463 | 0.653 | 77.46 | 10.702 |
| Financing Cash Flow
| -17,935,982.064 | 0 | 55.56 | 19.357 | 26.648 | 35.657 | 6.36 | 17.423 | 7.464 | 1.463 | 80.464 | 77.46 | 9.785 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0.01 | -0.019 | -0.028 | 0.032 | -0.006 | -0.015 | 0.034 | -0.009 | -0.009 | -0.014 | 0.001 | 0 | 0 |
| Net Change In Cash
| -17.936 | -16.313 | 36.045 | -3.701 | 5.756 | 12.946 | -17.426 | 1.601 | -23.783 | -16.427 | -21.518 | 78.814 | -4.627 |
| Cash At End Of Period
| 20.821 | 38.757 | 55.07 | 19.025 | 22.726 | 16.97 | 4.024 | 21.4 | 19.799 | 43.582 | 60.009 | 81.527 | 2.713 |